BioCryst Pharma (BCRX) – Hot Comments
-
BofA Securities Upgrades BioCryst Pharma (BCRX) to Buy on Pullback
-
Needham & Company Upgrades BioCryst Pharma (BCRX) to Buy, 'Pipeline Setback Provides Attractive Entry Opportunity'
-
-
-
-
-
-
-
-
-
-
-
Back to BCRX Stock Lookup